Understanding Meningocele In Spina Bifida

  • Anna SheasbyBachelor of Science - BS, Biomedical Sciences, General, The University of Edinburgh
  • Patience MutandiBSc. Medical Science (U. of Leeds), MBBS (CMU), MPH (U. of Chester)
  • Paramvir SinghRPh; Master of Pharmacy (MPharma), Pt BD Sharma University of Health Sciences, India

Get health & wellness advice into your inbox

Your privacy is important to us. Any information you provide to us via this website may be placed by us on servers. If you do not agree to these placements, please do not provide the information.

Best Milk Alternative

Introduction

Spina bifida is a neural tube defect where the spine and spinal cord do not develop correctly in the womb, causing gaps or missing vertebrae in the baby’s spine. Spina bifida symptoms can range from mild to serious impairments. Symptoms are dependent on the location of the spine opening and the size of the opening. The severity of symptoms and characteristics of the opening are used to classify the three main types of spina bifida:

  • Spina bifida occulta - It is the most common and mildest form, where 1+ vertebrae do not develop properly, but the gap is minuscule 
  • Myelomeningocele - It is the most severe form in which the baby’s spinal canal does not close along many vertebrae in the back
  • Meningocele (muh-NIN-guh-seal) - It is also a severe but rare form where protective membranes surrounding the spinal cord (meninges) protrude from the spine

File:Typesofspinabifida.jpg
By Centers for Disease Control and Prevention - Centers for Disease Control and Prevention, Public Domain, Link

Figure 1. Types of spina bifida - Centres for Disease Control and Prevention.

They can be grouped into two main types: 

  • Closed spina bifida - spina bifida occulta 
  • Open spina bifida - also known as spina bifida aperta (including myelomeningocele and meningocele) 

The latter category is more dangerous and problematic. 

File:Spina-bifida.jpg
By Centers for Disease Control and Prevention - Centers for Disease Control and Prevention, Public Domain, Link

Figure 2. Illustration of an infant with open spina bifida - Centres for Disease Control and Prevention.

Neural tube development in meningocele

During early pregnancy, the neural tube forms and eventually develops into the spine and spinal cord. The spine should close by the 4th week after conception.1

In meningocele, the neural tube fails to close, and a defect in the formation of vertebral arches means meninges protrude through the opening. These protrude through the dura and arachnoid mater of the meninges but not into the pia mater. This creates a sac that is filled with cerebrospinal fluid.2 Unlike myelomeningocele, the meningocele sac does not contain the spinal cord or nerve endings within the sac.

Furthermore, the large sac can exert pressure on the surrounding tissues, which leads to various degrees of neurological impairment, depending on the location along the spine. 90% of the abnormalities found are located in the lumbar and sacral regions of the vertebral column (lower back), and fewer in the cervical region (upper neck).

Causes and risk factors 

A main cause of spina bifida is thought to be genetics, responsible for 60-70%.3 There is no specific gene responsible (Mendelian inheritance) for spina bifida; however, it is a complex trait determined by many genes. The exact mode of inheritance is unknown, but researchers are working to determine it.

The other cause is environmental factors such as:

  • Insufficient folic acid - folate is the natural form of vitamin B9, which, when deficient, causes spina bifida, so folic acid supplements (the synthetic form) can be given to patients
  • Pregnant person assigned female at birth (AFAB) with diabetes/obesity - increases the risk of spina bifida by 2 to 10 times4
  • Specific medications - e.g., valproic acid to treat seizures
  • Family history - the risk is greater if one child has spina bifida, and even greater if a person AFAB has two children with spina bifida

Preventative strategies

Since folic acid deficiency increases the risk of spina bifida, taking 400 micrograms of folic acid supplements when trying to get pregnant and during the first 12 weeks of pregnancy has been found to significantly reduce the likelihood of spina bifida.

If you are at a higher risk, 5 milligrams of folic acid is prescribed. Eating foods naturally high in folate can be useful. These include leafy green vegetables like spinach and chickpeas/kidney beans.

In addition, carefully managing health during pregnancy, especially obesity and diabetes, is important. Furthermore, avoiding hot tubs or saunas, to not overheat the body, is recommended, but the evidence is less well supported.

Diagnosis

There are two categories in which diagnoses fall, first is before birth or prenatal and second is after birth or postnatal.

Prenatal

Spina bifida can be detected prenatally, and over 90% of cases are detected before birth.5 This is done primarily through ultrasound because it is non-invasive, cheap, and safe.

Although the spine closes by the 4th week of pregnancy, spine defects will only become apparent in ultrasounds by around weeks 20-22.

Abnormalities that can be detected include:

Spina bifida occulta does not present with intracranial abnormalities, unlike meningocele and myelomeningocele.6 Often, it is difficult to distinguish meningocele from myelomeningocele in utero. The later in pregnancy screening is undertaken, the greater the likelihood of being able to differentiate variations in spina bifida. 

Although ultrasound is the best diagnostic tool for detecting spina bifida, sometimes blood tests and amniocentesis are used to confirm the diagnosis or first indicate abnormalities. A maternal serum α-fetoprotein (MASFP) test detects α-fetoprotein, which at high levels indicates a neural tube defect.

However, high α-fetoprotein can also indicate multiple foetuses or being further along in pregnancy than expected, so it can be a less reliable technique. If spina bifida has been confirmed by an ultrasound, amniocentesis will be carried out. It involves using a needle to extract amniotic fluid to test for other genetic diseases. 

Prenatal diagnosis gives parents a prognosis of the baby’s condition. This means parents can make an informed choice whether to continue the pregnancy or terminate if they wish.

Postnatal 

After birth, a doctor carries out a physical examination. If the baby has myelomeningocele or meningocele, then the fluid-filled sac will be positioned outside of their lower back. A CT or MRI can be used to assess the extent of the defect and any potential damage to the spinal cord and nerves. This can show whether the spinal cord and nerves are within the sac or not. To differentiate between myelomeningocele and meningocele. Since spina bifida occulta does not have a sac outside of the body and often has mild symptoms, it is more difficult to diagnose.

Treatment for meningocele

Usually, the only treatment required for meningocele is surgical repair. This will happen soon after birth to prevent the chance of infection. During surgery, the surgeon will make an incision in the sac to drain cerebrospinal fluid, place the meninges back into the spinal canal and close the opening. The surgeon will also explore the spinal canal to assess if the patient has tethered cord syndrome. Tethered cord syndrome is a condition where tissue attaches to the spinal cord to limit mobility. If the condition is present, the spinal cord can usually be released in the same surgery.7 Afterwards, patients will be closely monitored in the neonatal unit and electrolytes and red blood cells are assessed.

Prognosis for meningocele 

Meningocele has a favourable prognosis because it has no neural involvement. The prognosis is also good since it can easily be surgically repaired. Problems can sometimes persist after repair, like weakness in bowel and bladder control, if the sac is positioned at the lumbar region of the spine.

Very occasionally, hydrocephalus (the accumulation of cerebrospinal fluid in the brain) occurs in patients with meningocele, where fluid increases pressure in the brain, potentially causing brain damage. It requires a ventriculoperitoneal shunt to alleviate pressure.8 This can be a lifelong problem as the shunt needs to be continuously replaced.

Additionally, babies with meningocele have a higher predisposition to allergy to latex than the general population; therefore, latex gloves, nipple dummies, etc, should be avoided for these babies.

Therefore, children with meningocele sometimes require ongoing care to manage any residual symptoms or complications. This can involve physical therapy to improve their mobility and strength, which may require seeing an occupational therapist. Despite this, individuals with meningocele can live normal lives, often unaffected by this form of spina bifida.

Summary

Spina bifida is a neural tube defect causing missing vertebrae in the spine. The defect can be closed in spina bifida occulta, or open as in meningocele and myelomeningocele. Open defects tend to have the greatest impact on an individual's quality of life. In meningocele, the meninges protrude outwards without affecting the spinal cord, leading to fewer neurological issues than myelomeningocele. The causes include genetic factors and environmental influences like insufficient folic acid and maternal health conditions. Diagnosis is primarily via prenatal ultrasound, with treatment involving surgical repair post-birth. Meningocele has a favourable prognosis with early intervention, though some complications like bladder issues and hydrocephalus occasionally persist.

References

  1. Moore KL, Persaud TVN, Torchia MG. The Developing Human E-Book: Clinically Oriented Embryology. Elsevier Health Sciences; 2015.
  2. Copp AJ, Adzick NS, Chitty LS, Fletcher JM, Holmbeck GN, Shaw GM. Spina Bifida. Nat Rev Dis Primers [Internet]. 2015 [cited 2024 Jul 22]; 1:15007. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898641/.
  3. Lupo PJ, Agopian AJ, Castillo H, Castillo J, Clayton GH, Dosa NP, et al. Genetic Epidemiology of Neural Tube Defects. J Pediatr Rehabil Med [Internet]. 2017 [cited 2024 Jul 22]; 10(3–4):189–94. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085973/.
  4. Mitchell LE, Adzick NS, Melchionne J, Pasquariello PS, Sutton LN, Whitehead AS. Spina bifida. The Lancet [Internet]. 2004 [cited 2024 Jul 22]; 364(9448):1885–95. Available from: https://www.sciencedirect.com/science/article/pii/S014067360417445X.
  5. Gotha L, Pruthi V, Abbasi N, Kulkarni AV, Church P, Drake JM, et al. Fetal spina bifida: What we tell the parents. Prenatal Diagnosis [Internet]. 2020 [cited 2024 Jul 22]; 40(12):1499–507. Available from: https://obgyn.onlinelibrary.wiley.com/doi/10.1002/pd.5802.
  6. Ghi T, Pilu G, Falco P, Segata M, Carletti A, Cocchi G, et al. Prenatal diagnosis of open and closed spina bifida. Ultrasound in Obstet & Gyne [Internet]. 2006 [cited 2024 Jul 22]; 28(7):899–903. Available from: https://obgyn.onlinelibrary.wiley.com/doi/10.1002/uog.3865.
  7. Yun-Hai S, Nan B, Ping-Ping G, Bo Y, Cheng C. Is repair of the protruded meninges sufficient for treatment of meningocele? Childs Nerv Syst. 2015; 31(11):2135–40.
  8. Verhoef M, Lurvink M, Barf HA, Post MWM, Asbeck FWA van, Gooskens RHJM, et al. High prevalence of incontinence among young adults with spina bifida: description, prediction and problem perception. Spinal Cord [Internet]. 2005 [cited 2024 Jul 22]; 43(6):331–40. Available from: https://www.nature.com/articles/3101705.
  9. Ausili E, Tabacco F, Focarelli B, Nucera E, Patriarca G, Rendeli C. Prevalence of latex allergy in spina bifida: genetic and environmental risk factors. Eur Rev Med Pharmacol Sci. 2007; 11(3):149–53.

Get health & wellness advice into your inbox

Your privacy is important to us. Any information you provide to us via this website may be placed by us on servers. If you do not agree to these placements, please do not provide the information.

Best Milk Alternative
[optin-monster-inline slug="yw0fgpzdy6fjeb0bbekx"]
This content is purely informational and isn’t medical guidance. It shouldn’t replace professional medical counsel. Always consult your physician regarding treatment risks and benefits. See our editorial standards for more details.

Get our health newsletter

Get daily health and wellness advice from our medical team.
Your privacy is important to us. Any information you provide to this website may be placed by us on our servers. If you do not agree do not provide the information.

Anna Sheasby

BSc Biomedical Sciences, University of Edinburgh

Anna is a BSc Biomedical Sciences student at the University of Edinburgh with a strong foundational knowledge in physiology, molecular biology, pharmacology, and reproductive biology. By combining her scientific expertise with clear and effective communication in her writing she aims to make complex medical concepts accessible to a wide audience.

Anna has a keen interest in advancing our understanding of reproductive health driven by her passion to improve women’s healthcare outcomes and contribute to meaningful research. Alongside medical writing, she is committed to exploring complex scientific questions through laboratory work, data analysis and other evidence-based writing.

my.klarity.health presents all health information in line with our terms and conditions. It is essential to understand that the medical information available on our platform is not intended to substitute the relationship between a patient and their physician or doctor, as well as any medical guidance they offer. Always consult with a healthcare professional before making any decisions based on the information found on our website.
Klarity is a citizen-centric health data management platform that enables citizens to securely access, control and share their own health data. Klarity Health Library aims to provide clear and evidence-based health and wellness related informative articles. 
Email:
Klarity / Managed Self Ltd
Alum House
5 Alum Chine Road
Westbourne Bournemouth BH4 8DT
VAT Number: 362 5758 74
Company Number: 10696687

Phone Number:

 +44 20 3239 9818
arrow-right